Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells
Open Access
- 7 July 2010
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 9 (1), 178
- https://doi.org/10.1186/1476-4598-9-178
Abstract
Background Trichostatin A (TSA), a potent inhibitor of histone deacetylases exhibits strong anti-tumor and growth inhibitory activities, but its mechanism(s) of action is not completely understood. Osteopontin (OPN) is a secreted glycoprotein which has long been associated with tumor metastasis. Elevated OPN expression in various metastatic cancer cells and the surrounding stromal cells often correlates with enhanced tumor formation and metastasis. To investigate the effects of TSA on OPN transcription, we analyzed a proximal segment of OPN promoter in cervical carcinoma cells. Results In this paper, we for the first time report that TSA suppresses PMA-induced OPN gene expression in human cervical carcinoma cells and previously unidentified AP-1 transcription factor is involved in this event. Deletion and mutagenesis analyses of OPN promoter led to the characterization of a proximal sequence (-127 to -70) that contain AP-1 binding site. This was further confirmed by gel shift and chromatin immunoprecipitation (ChIP) assays. Western blot and reverse transcription-PCR analyses revealed that TSA suppresses c-jun recruitment to the OPN promoter by inhibiting c-jun levels while c-fos expression was unaffected. Silencing HDAC1 followed by stimulation with PMA resulted in significant decrease in OPN promoter activity suggesting that HDAC1 but not HDAC3 or HDAC4 was required for AP-1-mediated OPN transcription. TSA reduces the PMA-induced hyperacetylation of histones H3 and H4 and recruitment of RNA pol II and TFIIB, components of preinitiation complex to the OPN promoter. The PMA-induced expression of other AP-1 regulated genes like cyclin D1 and uPA was also altered by TSA. Interestingly, PMA promoted cervical tumor growth in mice xenograft model was significantly suppressed by TSA. Conclusions In conclusion, these findings provide new insights into mechanisms underlying anticancer activity of TSA and blocking OPN expression at transcriptional level by TSA may act as novel therapeutic strategy for the management of cervical cancer.Keywords
This publication has 54 references indexed in Scilit:
- Trichostatin A activates the osteopontin gene promoter through AP1 siteBiochemical and Biophysical Research Communications, 2004
- Transcriptional regulation of human osteopontin promoter by C/EBPα and AML-1 in metastatic cancer cellsOncogene, 2004
- Deacetylase Activity Is Required for cAMP Activation of a Subset of CREB Target GenesPublished by Elsevier BV ,2003
- Controlling the double helixNature, 2003
- Tumor-derived Osteopontin Is Soluble, Not Matrix AssociatedJournal of Biological Chemistry, 2002
- Expression Profile of Histone Deacetylase 1 in Gastric Cancer TissuesJapanese Journal of Cancer Research, 2001
- Translating the Histone CodeScience, 2001
- OsteopontinCritical Reviews in Oral Biology & Medicine, 2000
- Secreted phosphoprotein mrna is induced during multi‐stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblastsInternational Journal of Cancer, 1990
- Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989